ArticlePloS one2025
Coagulation profiles and platelet parameters among preeclampsia, eclampsia, and normotensive pregnant women attending Comprehensive Specialized Hospital maternity wards, Northwest Ethiopia.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Platelet Count as a Marker of Disease Severity in Pregnancy-Induced Hypertension: A Cross-Sectional Study.Cureus · 2026Article
- Adverse Materno-Foetal Outcomes of Pre-Eclampsia at a Rural Tertiary Hospital in the Eastern Cape Province of South Africa.International journal of environmental research and public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertensive disorders of pregnancy affect about 10% of all pregnant women worldwide. A variety of hematological abnormalities may occur in women with pregnancy-induced hypertension. Thus, we aimed to compare coagulation profiles and platelet parameters among preeclampsia, eclampsia, and normotensive pregnant women in Northwest Ethiopia.
methodA comparative cross-sectional study was conducted at University of Gondar and Felegehiwot Comprehensive Specialized Hospital, maternity wards from June 20 to November 15, 2024. A total of 180 participants were recruited using the convenience sampling technique. Socio-demographic and clinical data were collected using a structured questionnaire and participants' medical records. Eight milliliters of blood specimens were collected from each study participant. Coagulation profiles and platelet parameters were measured using a Genrui coagulation analyzer and an automated Mindray BC-5150 hematological analyzer, respectively. Data were entered into epi-data version 4.6.0.6 and exported to the SPSS version 26 software for analysis. Descriptive data were presented using tables and frequencies. One-way ANOVA and Kruskal-Wallis tests were used for normally distributed and skewed data, respectively. A p < 0.05 was considered statistically significant.
resultsA total of 180 pregnant women were enrolled/included in this study. The median PT and aPTT showed prolongation in preeclampsia and eclampsia patients, as compared to normotensive pregnant women, indicating a significant difference (p < 0.001) and (P = 0.002) respectively. The mean ± SD of mean platelet volume and PDW showed higher values in preeclampsia and eclampsia patients, as compared to normotensive pregnant women, demonstrating both a significant difference (P < 0.001). On the other hand, the mean platelet count in preeclampsia and eclampsia patients, were lower than in normotensive pregnant women, with a significant difference (p < 0.001). CONCLUSION AND RECOMMENDATIONS: In this study, alteration of coagulation and platelet parameters were observed in preeclampsia and eclampsia pregnant womens compared to normotensive controls. Thus, a routine laboratory test of coagulation and platelet parameters for pregnant women with preeclampsia and eclampsia could be applicable to reduce the risk of coaglation and platelet abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.